Nanotechnology Now - Press Release: MFIC to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Home > Press > MFIC to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Abstract:
MFIC Corporation (MFIC or the Company) announced that the Company will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference at the Mandarin Oriental Hotel in New York City on July 11, 2007 at 4:30 p.m. Eastern Time. Jack Swig, Vice President of Corporate Development and General Counsel, will provide an overview of the Company, review key research and development accomplishments and discuss upcoming corporate initiatives. A link to a live webcast of the presentation will be available on the home page of the Company's website, http://www.mficcorp.com . A replay of the presentation will be available for 90 days after the conference.

MFIC to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

NEWTON, MA | Posted on July 10th, 2007

####

About MFIC Corporation
MFIC Corporation, through its Microfluidics Division, designs, manufactures and distributes patented and proprietary high performance Microfluidizer® materials processing and formulation equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid particles available, and has provided manufacturing systems for nanoparticle products for more than 15 years.

The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers.

For more information, please click here

Contacts:
MFIC Corporation
Jack M. Swig, 617-969-5452

or
MacDougall Biomedical Communications
Sarah Cavanaugh, 508-647-0209

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: